Related Experiment Video
Updated: Mar 9, 2026

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
mTORC1 activation downregulates FGFR3 and PTH/PTHrP receptor in articular chondrocytes to initiate osteoarthritis
1Academy of Orthopedics, Guangdong Province, Department of Orthopedics, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
Objective:
Articular chondrocyte activation, involving aberrant proliferation and prehypertrophic differentiation, is essential for osteoarthritis (OA) initiation and progression. Disruption of mechanistic target of rapamycin complex 1 (mTORC1) promotes chondrocyte autophagy and survival, and decreases the severity of experimental OA. However, the role of cartilage mTORC1 activation in OA initiation is unknown. In this study, we elucidated the specific role of mTORC1 activation in OA initiation, and identify the underlying mechanisms.
Method:
Expression of mTORC1 in articular cartilage of OA patients and OA mice was assessed by immunostaining. Cartilage-specific tuberous sclerosis complex 1 (Tsc1, mTORC1 upstream inhibitor) knockout (TSC1CKO) and inducible Tsc1 KO (TSC1CKOER) mice were generated. The functional effects of mTORC1 in OA initiation and development on its downstream targets were examined by immunostaining, western blotting and qPCR.
Results:
Articular chondrocyte mTORC1 was activated in early-stage OA and in aged mice. TSC1CKO mice exhibited spontaneous OA, and TSC1CKOER mice (from 2 months) exhibited accelerated age-related and DMM-induced OA phenotypes, with aberrant chondrocyte proliferation and hypertrophic differentiation. This was associated with hyperactivation of mTORC1 and dramatic downregulation of FGFR3 and PPR, two receptors critical for preventing chondrocyte proliferation and differentiation. Rapamycin treatment reversed these phenotypes in KO mice. Furthermore, in vitro rescue experiments demonstrated that p73 and ERK1/2 may mediate the negative regulation of FGFR3 and PPR by mTORC1.
Conclusion:
mTORC1 activation stimulates articular chondrocyte proliferation and differentiation to initiate OA, in part by downregulating FGFR3 and PPR.
Insights
Mechanistic target of rapamycin complex 1 (mTORC1) activation drives osteoarthritis (OA) by promoting articular chondrocyte proliferation and differentiation, partly through downregulating FGFR3 and PPR receptors.
Area of Science:
- Biomedical research
- Molecular biology
- Osteoarthritis research
Background:
- Articular chondrocyte activation is crucial for osteoarthritis (OA) development.
- Mechanistic target of rapamycin complex 1 (mTORC1) disruption aids chondrocyte survival and reduces OA severity.
- The specific role of cartilage mTORC1 activation in OA initiation remains unclear.
Purpose of the Study:
- To investigate the precise role of mTORC1 activation in initiating osteoarthritis.
- To identify the molecular mechanisms underlying mTORC1's role in OA initiation.
Main Methods:
- Immunostaining to assess mTORC1 expression in human and mouse OA cartilage.
- Generation of cartilage-specific Tsc1 knockout mice (TSC1CKO and TSC1CKOER).
- Analysis of downstream targets using western blotting and qPCR.
Main Results:
- mTORC1 was activated in early OA and aged mice.
- TSC1CKO mice developed spontaneous OA; TSC1CKOER mice showed accelerated OA phenotypes.
- Hyperactivated mTORC1 led to downregulated FGFR3 and PPR, promoting chondrocyte proliferation and differentiation.
- Rapamycin treatment reversed OA phenotypes in knockout mice.
Conclusions:
- mTORC1 activation initiates OA by stimulating articular chondrocyte proliferation and differentiation.
- This process is partly mediated by the downregulation of FGFR3 and PPR receptors.
More Related Videos
08:42A Reproducible Cartilage Impact Model to Generate Post-Traumatic Osteoarthritis in the Rabbit
Published on: November 21, 2023
12:23Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
Published on: April 24, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Osteoclasts in Bone Remodeling
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway